PPI Linked to Lower, Not Higher, Gastric Cancer Mortality Risk Nancy A. Melville September 15, 2026 Am J Gastroenterol. 2026; doi:10.14309/ajg.0000000000004075

https://www.medscape.com/viewarticle/ppi-linked-lower-not-higher-gastric-cancer-mortality-risk-2026a1000y5i?src= Contrary to concerns that the use of proton pump inhibitors (PPI) may mask symptoms of gastric cancer and hence delay detection, the commonly used medication instead shows a link to an earlier stage of diagnosis and decreased risk for mortality.

High CLL Remission Seen With First-Line Triplet Regimen Nancy A. Melville September 15, 2026

https://www.medscape.com/viewarticle/high-cll-remission-seen-first-line-triplet-regimen-2026a1000y5j?src= Outcomes were positive, but toxicities were concerning in patients with chronic lymphocytic leukemia (CLL) treated with a combination of the noncovalent Bruton tyrosine kinase inhibitor (BTKi) pirtobrutinib with venetoclax and obinutuzumab in the first-line setting.

FET-PET Agent Approved for Glioma Imaging M. Alexander Otto, MMSc September 15, 2026

https://www.medscape.com/viewarticle/fet-pet-agent-approved-glioma-imaging-2026a1000y6x?src= The FDA has approved floretyrosine F18 (Pixclara, Telix Pharmaceuticals), an intravenous PET imaging agent, for differentiating recurrent or progressive glioma from treatment-related change, in conjunction with other diagnostic evaluations, in adults and children aged 1 month or older. Floretyrosine F18 is the first floretyrosine PET (FET-PET) agent approved in the US for glioma, Telix said in a press release.

Sunscreen Myths: How Evidence Morphed Into Skepticism

https://www.medscape.com/viewarticle/sunscreen-myths-how-evidence-morphed-skepticism-2026a1000tls?ecd=mkm_ret_260915_mscpmrk-OUS_ExcNews_etid8669286&uac=148436CN&impID=8669286 I have started to recognize the cadence of this question, which typically comes in late June and is some version of: “Is sunscreen actually safe? I saw that it gets into your blood.” It is a fair question. Not because sunscreen is harmful — it is not — but because the information patients encounter is often confusing and incomplete. The topic is worth exploring now because there is new evidence on absorption, ongoing questions about product testing, and, for the first time in decades, a new sunscreen active ingredient available in the US.

ESC 2026: Clinical Trials That Could Change Practice Gabriel Steg, MD (+ + + +)

https://www.medscape.com/viewarticle/esc-2026-clinical-trials-could-change-practice-2026a1000t32?ecd=mkm_ret_260915_mscpmrk-OUS_ExcNews_etid8669580&uac=148436CN&impID=8669580 Commonly Asked by HCPs When should statins be continued or initiated in very elderly adults with cardiovascular risk? https://www.medscape.com/ai-search?query=When%20should%20statins%20be%20continued%20or%20initiated%20in%20very%20elderly%20adults%20with%20cardiovascular%20risk&&ecd=mkm_ret_260915_mscpmrk-OUS_ExcNews_etid8669580&uac=148436CN&impID=8669580 What is the evidence for metformin use in heart failure without diabetes? https://www.medscape.com/ai-search?query=What%20is%20the%20evidence%20for%20metformin%20use%20in%20heart%20failure%20without%20diabetes&&ecd=mkm_ret_260915_mscpmrk-OUS_ExcNews_etid8669580&uac=148436CN&impID=8669580 How is coronary revascularization timed around TAVI in patients with concomitant coronary disease? https://www.medscape.com/ai-search?query=How%20is%20coronary%20revascularization%20timed%20around%20TAVI%20in%20patients%20with%20concomitant%20coronary%20disease&&ecd=mkm_ret_260915_mscpmrk-OUS_ExcNews_etid8669580&uac=148436CN&impID=8669580

Patient-Generated and Real-World Data Throughout the Medical Device Life Cycle

Please click on the link below to access the course “Patient-Generated and Real-World Data Throughout the Medical Device Life Cycle.” You will need to download all accompanying FDA resources for this course by clicking on the links located directly below this YouTube video in “Course Description Details to Accompany YouTube Course Video.” https://www.fda.gov/about-fda/division-patient-centered-development/cdrh-patient-education-program-course-2-video-patient-generated-and-real-world-data-throughout?utm_medium=email&utm_source=govdelivery

Mysterious disease sending young, healthy Texas workers into kidney failure +...

https://www.foxnews.com/lifestyle Mysterious disease sending young, healthy Texas workers into kidney failure Physicians at Houston hospitals are reportedly treating more men in their 20s and 30s By Shiv Sudhakar Fox News Published September 15, 2026 7:00am EDT https://www.foxnews.com/health/mysterious-disease-sending-young-healthy-texas-workers-kidney-failure